LON:CLIN - Clinigen Healthcare Stock Price, Price Target & More

GBX 910 -1.00 (-0.11 %)
(As of 04/23/2018 01:00 AM ET)
Previous CloseGBX 910
Today's RangeGBX 906 - GBX 915
52-Week RangeGBX 751.50 - GBX 1,187
Volume548,678 shs
Average Volume432,646 shs
Market Capitalization£1.12 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Clinigen Healthcare (LON:CLIN)

Clinigen Healthcare logoClinigen Group plc operates as a specialty pharmaceutical and services company. Its Clinigen Clinical Trial Services segment supplies and manages commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs, and rescue therapies. The company's Idis Managed Access segment is involved in the consultancy, development, management, and implementation of managed access programs for biotechnology and pharmaceutical companies. Its Idis Global Access segment provides ethical access to post approval and short-supply medicines, in regions where patients have low or non-existent access to these drugs. The company's Clinigen Specialty Pharmaceuticals segment manufactures and distributes its own and in-licensed specialist, and hospital-only medicines worldwide. It offers Ethyol for reducing the incidence of dry mouth in patients undergoing high dose radiation treatment; Cardioxane, a cardioprotective agent that is used to prevent the cardiotoxicity of anthracycline chemotherapy for patients with advanced or metastatic breast cancer; Savene and Totect, which are used as emergency treatments for extravasation at the site of injection of oncology treatment; and Foscavir, an anti-viral targeting human herpes viruses and is used primarily in bone marrow transplant patients. Its Link Healthcare business distributes pharmaceutical products in South Africa and the Asia-Pacific. The company has a strategic alliance with Cumberland Pharmaceuticals Inc. Clinigen Group plc was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.

Receive CLIN News and Ratings via Email

Sign-up to receive the latest news and ratings for CLIN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Delivery
Sub-IndustryN/A
SectorMedical
SymbolLON:CLIN
CUSIPN/A
Phone+44-1283-495010

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins7.15%
Return on Equity8.14%
Return on Assets4.26%

Miscellaneous

EmployeesN/A
Outstanding Shares122,220,000

How to Become a New Pot Stock Millionaire

Clinigen Healthcare (LON:CLIN) Frequently Asked Questions

What is Clinigen Healthcare's stock symbol?

Clinigen Healthcare trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."

How often does Clinigen Healthcare pay dividends? What is the dividend yield for Clinigen Healthcare?

Clinigen Healthcare declared a dividend on Tuesday, February 27th. Stockholders of record on Thursday, March 22nd will be given a dividend of GBX 1.76 per share on Thursday, April 12th. This represents a dividend yield of 0.2%. The ex-dividend date is Thursday, March 22nd. The official announcement can be viewed at this link. View Clinigen Healthcare's Dividend History.

How were Clinigen Healthcare's earnings last quarter?

Clinigen Healthcare (LON:CLIN) issued its earnings results on Tuesday, February, 27th. The company reported $21.20 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $20.30 by $0.90. The business had revenue of $167.80 million for the quarter. Clinigen Healthcare had a net margin of 7.15% and a return on equity of 8.14%. View Clinigen Healthcare's Earnings History.

What price target have analysts set for CLIN?

6 brokerages have issued 12-month price objectives for Clinigen Healthcare's stock. Their predictions range from GBX 970 to GBX 1,360. On average, they expect Clinigen Healthcare's stock price to reach GBX 1,212.17 in the next year. View Analyst Ratings for Clinigen Healthcare.

Who are some of Clinigen Healthcare's key competitors?

Who are Clinigen Healthcare's key executives?

Clinigen Healthcare's management team includes the folowing people:
  • Mr. Shaun Edward Chilton, CEO & Director (Age 50)
  • Mr. Martin Abell, CFO & Director
  • Ms. Debra Ainge, Chief Operating Officer
  • Mr. Paul Thomas, Chief Technical Officer
  • Matt Parrish, Head of Investor Relations

Has Clinigen Healthcare been receiving favorable news coverage?

Headlines about CLIN stock have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Clinigen Healthcare earned a news sentiment score of 0.05 on Accern's scale. They also gave media coverage about the company an impact score of 46.85 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of Clinigen Healthcare?

Shares of CLIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Clinigen Healthcare's stock price today?

One share of CLIN stock can currently be purchased for approximately GBX 910.

How big of a company is Clinigen Healthcare?

Clinigen Healthcare has a market capitalization of £1.12 billion.

How can I contact Clinigen Healthcare?

Clinigen Healthcare's mailing address is Pitcairn House Crown Square, First Avenue, STAFFORDSHIRE, DE14 2WW, United Kingdom. The company can be reached via phone at +44-1283-495010.


MarketBeat Community Rating for Clinigen Healthcare (CLIN)

Community Ranking:  4.0 out of 5 (star star star star)
Outperform Votes:  303 (Vote Outperform)
Underperform Votes:  80 (Vote Underperform)
Total Votes:  383
MarketBeat's community ratings are surveys of what our community members think about Clinigen Healthcare and other stocks. Vote "Outperform" if you believe CLIN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLIN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Clinigen Healthcare (LON:CLIN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Clinigen Healthcare in the last 12 months. Their average twelve-month price target is GBX 1,212.17The high price target for CLIN is GBX 1,360 and the low price target for CLIN is GBX 970. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.832.832.832.75
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 1,212.17GBX 1,222.17GBX 1,222.17GBX 1,078.75

Clinigen Healthcare (LON:CLIN) Consensus Price Target History

Price Target History for Clinigen Healthcare (LON:CLIN)

Clinigen Healthcare (LON:CLIN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
4/4/2018Peel HuntReiterated RatingBuyView Rating Details
3/27/2018Berenberg BankLower Price TargetBuyGBX 1,220 -> GBX 1,160View Rating Details
2/27/2018Numis SecuritiesReiterated RatingAddGBX 1,208View Rating Details
1/17/2018N+1 SingerReiterated RatingBuyGBX 1,225View Rating Details
11/7/2017Royal Bank of CanadaReiterated RatingOutperformGBX 1,360View Rating Details
5/22/2017Stifel NicolausReiterated RatingBuyGBX 970View Rating Details
(Data available from 4/23/2016 forward)

Earnings

Clinigen Healthcare (LON:CLIN) Earnings History and Estimates Chart

Earnings by Quarter for Clinigen Healthcare (LON:CLIN)

Clinigen Healthcare (LON CLIN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2018S1 2018GBX 20.30GBX 21.20£167.80 millionViewN/AView Earnings Details
9/28/2017Y 2017GBX 41.20GBX 41.80£302.30 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Clinigen Healthcare (LON:CLIN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/27/2018GBX 1.760.2%3/22/20183/22/20184/12/2018
9/28/2017GBX 3.400.32%11/9/201711/9/201712/1/2017
3/15/2017GBX 1.600.2%3/23/20173/23/20174/13/2017
9/28/2016GBX 2.700.38%11/3/201611/3/201611/25/2016
3/2/2016GBX 1.300.2%3/17/20163/17/20164/8/2016
9/22/2015GBX 2.300.32%10/15/201510/15/201511/6/2015
9/24/2014GBX 2.100.46%10/16/201410/16/201411/7/2014
2/26/2014GBX 10.19%3/5/20143/5/20143/28/2014
(Data available from 1/1/2013 forward)

Insider Trades

Clinigen Healthcare (LON CLIN) Insider Trading and Institutional Ownership History

Insider Trading History for Clinigen Healthcare (LON:CLIN)

Clinigen Healthcare (LON CLIN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/23/2017Chris RiggInsiderSell4,955GBX 1,017£50,392.35
10/13/2017Shaun Edward ChiltonInsiderSell100,000GBX 1,150£1,150,000
10/2/2017John BaconInsiderSell250,000GBX 1,093£2,732,500
6/28/2017John BaconInsiderSell200,000GBX 843£1,686,000
6/22/2017Peter Georgeformer CEOSell500,000GBX 875£4,375,000
11/11/2016John BaconInsiderSell200,000GBX 717£1,434,000
10/18/2016Shaun Edward ChiltonInsiderSell97,246GBX 750£729,345
5/16/2016Abell,MartinInsiderBuy11,296GBX 518£58,513.28
10/7/2015Edward Chilton,ShaunInsiderSell412,778GBX 685£2,827,529.30
6/3/2015John HartupInsiderSell23,934GBX 644£154,134.96
(Data available from 1/1/2013 forward)

Headlines

Clinigen Healthcare (LON CLIN) News Headlines

Source:
DateHeadline
Numis Securities Downgrades Clinigen Healthcare (CLIN) to AddNumis Securities Downgrades Clinigen Healthcare (CLIN) to Add
www.americanbankingnews.com - April 17 at 7:34 PM
Clinigen Healthcare (CLIN) Rating Reiterated by Peel HuntClinigen Healthcare (CLIN) Rating Reiterated by Peel Hunt
www.americanbankingnews.com - April 9 at 10:55 PM
Clinigen Healthcare (CLIN) Downgraded by Peel Hunt to AddClinigen Healthcare (CLIN) Downgraded by Peel Hunt to Add
www.americanbankingnews.com - April 9 at 2:26 PM
Clinigen Healthcare (CLIN) Rating Increased to Buy at Peel HuntClinigen Healthcare (CLIN) Rating Increased to Buy at Peel Hunt
www.americanbankingnews.com - April 7 at 7:17 PM
Clinigen Healthcare (CLIN) Receives Average Rating of "Buy" from AnalystsClinigen Healthcare (CLIN) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - April 6 at 1:36 AM
Clinigen Groups (CLIN) Buy Rating Reiterated at Peel HuntClinigen Group's (CLIN) Buy Rating Reiterated at Peel Hunt
www.americanbankingnews.com - April 4 at 12:31 PM
Clinigen Groups (CLIN) "Buy" Rating Reaffirmed at Peel HuntClinigen Group's (CLIN) "Buy" Rating Reaffirmed at Peel Hunt
www.americanbankingnews.com - April 3 at 10:30 PM
Clinigen Group (CLIN) Now Covered by Berenberg BankClinigen Group (CLIN) Now Covered by Berenberg Bank
www.americanbankingnews.com - April 2 at 4:46 PM
Clinigen Group (CLIN) Receives "Outperform" Rating from Royal Bank of CanadaClinigen Group (CLIN) Receives "Outperform" Rating from Royal Bank of Canada
www.americanbankingnews.com - April 1 at 5:22 PM
Clinigen Group (CLIN) Price Target Cut to GBX 1,160Clinigen Group (CLIN) Price Target Cut to GBX 1,160
www.americanbankingnews.com - March 28 at 9:16 AM
Clinigen Group (CLIN) Rating Reiterated by Peel HuntClinigen Group (CLIN) Rating Reiterated by Peel Hunt
www.americanbankingnews.com - March 27 at 9:10 PM
Clinigen Group (CLIN) Earns Add Rating from Numis SecuritiesClinigen Group (CLIN) Earns Add Rating from Numis Securities
www.americanbankingnews.com - March 27 at 9:10 PM
Berenberg Bank Upgrades Clinigen Group (CLIN) to BuyBerenberg Bank Upgrades Clinigen Group (CLIN) to Buy
www.americanbankingnews.com - March 27 at 1:18 PM
Peel Hunt Reiterates Buy Rating for Clinigen Group (CLIN)Peel Hunt Reiterates Buy Rating for Clinigen Group (CLIN)
www.americanbankingnews.com - March 26 at 12:04 AM
Clinigen Group (CLIN) Receives Add Rating from Numis SecuritiesClinigen Group (CLIN) Receives Add Rating from Numis Securities
www.americanbankingnews.com - March 24 at 10:38 PM
Edited Transcript of CLIN.L earnings conference call or presentation 27-Feb-18 9:30am GMTEdited Transcript of CLIN.L earnings conference call or presentation 27-Feb-18 9:30am GMT
finance.yahoo.com - March 18 at 8:28 AM
Clinigen Group PLC to Issue Dividend of GBX 1.76 (CLIN)Clinigen Group PLC to Issue Dividend of GBX 1.76 (CLIN)
www.americanbankingnews.com - March 17 at 10:37 AM
Clinigen Group PLC (CLIN) Receives Consensus Rating of "Buy" from AnalystsClinigen Group PLC (CLIN) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - March 12 at 1:54 AM
Clinigen Group Plc: Good H1 Performance with Adjusted EPS up 13 ... - Business Wire (press release)Clinigen Group Plc: Good H1 Performance with Adjusted EPS up 13 ... - Business Wire (press release)
www.businesswire.com - February 28 at 8:28 AM
Clinigen Group (CLIN) Releases  Earnings Results, Beats Expectations By $0.90 EPSClinigen Group (CLIN) Releases Earnings Results, Beats Expectations By $0.90 EPS
www.americanbankingnews.com - February 27 at 8:28 AM
Clinigen Group PLC (CLIN) Receives Consensus Rating of "Buy" from BrokeragesClinigen Group PLC (CLIN) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - February 15 at 1:28 AM
Clinigen Group Plc (LON:CLIN): Time For A Financial Health CheckClinigen Group Plc (LON:CLIN): Time For A Financial Health Check
finance.yahoo.com - February 12 at 3:51 PM
Newly Published Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma PatientsNewly Published Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity For Multiple Myeloma Patients
finance.yahoo.com - January 30 at 10:27 AM
Clinigen Group PLC (CLIN) Given Average Rating of "Buy" by BrokeragesClinigen Group PLC (CLIN) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - January 21 at 1:40 AM
Clinigen Group To Record 10% Growth In Interim Gross ProfitClinigen Group To Record 10% Growth In Interim Gross Profit
www.morningstar.co.uk - January 17 at 9:01 AM
Clinigen Groups (CLIN) Buy Rating Reaffirmed at N+1 SingerClinigen Group's (CLIN) Buy Rating Reaffirmed at N+1 Singer
www.americanbankingnews.com - January 17 at 6:50 AM
Clinigen Group (CLIN) Stock Rating Reaffirmed by N+1 SingerClinigen Group (CLIN) Stock Rating Reaffirmed by N+1 Singer
www.americanbankingnews.com - December 31 at 7:30 AM
Estimating The Fair Value Of Clinigen Group Plc (LON:CLIN)Estimating The Fair Value Of Clinigen Group Plc (LON:CLIN)
finance.yahoo.com - December 28 at 4:05 PM
Clinigen Group PLC (CLIN) Given Average Rating of "Buy" by AnalystsClinigen Group PLC (CLIN) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - December 27 at 1:30 AM
Flavor Of The Month: Scientific Digital Imaging And MoreFlavor Of The Month: Scientific Digital Imaging And More
finance.yahoo.com - December 19 at 9:12 AM
Did Clinigen Group Plc (AIM:CLIN) Create Value For Investors Over The Past Year?Did Clinigen Group Plc (AIM:CLIN) Create Value For Investors Over The Past Year?
finance.yahoo.com - December 11 at 5:48 PM
Clinigen Group PLC (CLIN) Given Consensus Rating of "Buy" by BrokeragesClinigen Group PLC (CLIN) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - December 2 at 1:50 AM
DIRECTOR DEALINGS: Clinigen Chief Business Officer Sells SharesDIRECTOR DEALINGS: Clinigen Chief Business Officer Sells Shares
www.morningstar.co.uk - November 24 at 11:10 AM
Chris Rigg Sells 4,955 Shares of Clinigen Group PLC (CLIN) StockChris Rigg Sells 4,955 Shares of Clinigen Group PLC (CLIN) Stock
www.americanbankingnews.com - November 24 at 7:46 AM
(artesunate for injection) in South Africa for the Treatment of Patients with Severe Malaria - Business Wire (press release)(artesunate for injection) in South Africa for the Treatment of Patients with Severe Malaria - Business Wire (press release)
www.businesswire.com - November 23 at 4:01 AM
Should Clinigen Group Plc’s (AIM:CLIN) Earnings Decline In Recent Times Worry You?Should Clinigen Group Plc’s (AIM:CLIN) Earnings Decline In Recent Times Worry You?
finance.yahoo.com - November 20 at 6:21 PM
Clinigen Group PLC (CLIN) Given Average Recommendation of "Buy" by BrokeragesClinigen Group PLC (CLIN) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - November 7 at 5:52 AM
Clinigen Group PLC (CLIN) Raises Dividend to GBX 3.40 Per ShareClinigen Group PLC (CLIN) Raises Dividend to GBX 3.40 Per Share
www.americanbankingnews.com - November 4 at 9:32 AM
OBERWEIS ASSET UK Regulatory Announcement: Form 8.3 ... - Business Wire (press release)OBERWEIS ASSET UK Regulatory Announcement: Form 8.3 ... - Business Wire (press release)
www.businesswire.com - October 31 at 11:27 PM
What Should We Expect From Clinigen Group Plc’s (AIM:CLIN) Earnings Over The Next Year?What Should We Expect From Clinigen Group Plc’s (AIM:CLIN) Earnings Over The Next Year?
finance.yahoo.com - October 30 at 4:00 PM
Clinigen Group Plc breached its 50 day moving average in a Bearish Manner : CLIN-GB : October 25, 2017Clinigen Group Plc breached its 50 day moving average in a Bearish Manner : CLIN-GB : October 25, 2017
finance.yahoo.com - October 25 at 5:43 AM
Clinigen Acquires Japan’s Largest Supplier of Unlicensed MedicinesClinigen Acquires Japan’s Largest Supplier of Unlicensed Medicines
finance.yahoo.com - October 23 at 2:40 AM
Hargreave Hale LTD : Form 8.3 - [Clinigen Group plc] - London South East (blog)Hargreave Hale LTD : Form 8.3 - [Clinigen Group plc] - London South East (blog)
www.lse.co.uk - October 19 at 4:43 AM
Clinigen Group Plc :CLIN-GB: Earnings Analysis: 2017 By the Numbers : October 17, 2017Clinigen Group Plc :CLIN-GB: Earnings Analysis: 2017 By the Numbers : October 17, 2017
finance.yahoo.com - October 17 at 11:01 PM
CORRECT(Oct 16): DIRECTOR DEALINGS: Clinigen Group Chief Sells SharesCORRECT(Oct 16): DIRECTOR DEALINGS: Clinigen Group Chief Sells Shares
www.morningstar.co.uk - October 17 at 6:01 PM
DIRECTOR DEALINGS: Clinigen Group Chief Sells Shares To Buy HouseDIRECTOR DEALINGS: Clinigen Group Chief Sells Shares To Buy House
www.morningstar.co.uk - October 16 at 6:03 PM
Shaun Edward Chilton Sells 100,000 Shares of Clinigen Group PLC (CLIN) StockShaun Edward Chilton Sells 100,000 Shares of Clinigen Group PLC (CLIN) Stock
www.americanbankingnews.com - October 16 at 4:32 PM
Form 8.5 (EPT/RI) - Clinigen Group Plc - London South East (blog)Form 8.5 (EPT/RI) - Clinigen Group Plc - London South East (blog)
www.lse.co.uk - October 11 at 11:49 PM
Insider Selling: Clinigen Group PLC (CLIN) Insider Sells 250,000 Shares of StockInsider Selling: Clinigen Group PLC (CLIN) Insider Sells 250,000 Shares of Stock
www.americanbankingnews.com - October 3 at 7:36 AM
Clinigen Group plc: Full Year ResultsClinigen Group plc: Full Year Results
finance.yahoo.com - October 2 at 5:24 PM

SEC Filings

Clinigen Healthcare (LON:CLIN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Clinigen Healthcare (LON CLIN) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.